2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

被引：663

作者：

Steffel, Jan ^{[1
]}

Collins, Ronan ^{[2
]}

Antz, Matthias ^{[3
]}

Cornu, Pieter ^{[4
]}

Desteghe, Lien ^{[5
,6
,7
]}

Haeusler, Karl Georg ^{[8
]}

Oldgren, Jonas ^{[9
,10
]}

Reinecke, Holger ^{[11
]}

Roldan-Schilling, Vanessa ^{[12
]}

Rowell, Nigel

Sinnaeve, Peter ^{[13
]}

Vanassche, Thomas ^{[13
]}

Potpara, Tatjana ^{[14
]}

Camm, A. John ^{[15
]}

Heidbuechel, Hein ^{[5
,6
,7
]}

Lip, Gregory Y. H. ^{[16
,17
,18
]}

Deneke, Thomas ^{[19
]}

Dagres, Nikolaos ^{[20
]}

Boriani, Giuseppe ^{[21
]}

Chao, Tze-Fan ^{[22
,23
,24
]}

Choi, Eue-Keun ^{[25
]}

Hills, Mellanie True ^{[26
]}

Santos, Itamar de Souza ^{[27
,28
]}

Lane, Deirdre A. ^{[16
,17
,18
]}

Atar, Dan ^{[29
,30
]}

Joung, Boyoung ^{[31
]}

Cole, Oana Maria ^{[16
,17
]}

Field, Mark ^{[16
,17
]}

机构：

[1] Univ Heart Ctr Zurich, Dept Cardiol, Div Electrophysiol, Zurich, Switzerland

[2] Tallaght Univ Hosp, Age Related Hlth Care, Dept Gerontol, Trinity Coll, Dublin, Ireland

[3] Hosp Braunschweig, Dept Electrophysiol, Braunschweig, Germany

[4] Vrije Univ Brussel, Fac Med & Pharm, Res Grp Clin Pharmacol & Clin Pharm, Brussels, Belgium

[5] Antwerp Univ, Cardiol, Antwerp, Belgium

[6] Univ Hosp, Antwerp, Belgium

[7] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium

[8] Univ Klinikum Wurzburg, Dept Neurol, Wurzburg, Germany

[9] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden

[10] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

[11] Univ Hosp Munster, Dept Cardiol Coronary & Peripheral Vasc Dis 1, Heart Failure, Munster, Germany

[12] Univ Murcia, Murcia, Spain

[13] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[14] Univ Belgrade, Sch Med, Belgrade, Serbia

[15] St Georges Univ, Mol & Clin Sci Inst, Cardiol Clin Acad Grp, London, England

[16] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England

[17] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England

[18] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark

[19] Heart Ctr RHON KLINIKUM, Clin Intervent Electrophysiol, Campus Bad Neustadt, Bad Neustadt an der Saale, Germany

[20] Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany

[21] Univ Modena & Reggio Emilia, Policlin Modena, Cardiol Div, Dept Biomed Metab & Neural Sci, Modena, Italy

[22] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan

[23] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[24] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan

[25] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[26] StopAfiborg, POB 541, Greenwood, TX 76246 USA

[27] Univ Sao Paulo, Hosp Univ, Ctr Pesquisa Clin & Epidemiol, Sao Paulo, Brazil

[28] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil

[29] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway

[30] Univ Oslo, Inst Clin Sci, Oslo, Norway

[31] Yonsei Univ, Cardiol Dept, Coll Med, Seoul, South Korea

来源：

EUROPACE | 2021年 / 23卷 / 10期

关键词：

NOACs; DOACs; apixaban; dabigatran; edoxaban; rivaroxaban; FACTOR-XA INHIBITOR; DIRECT THROMBIN INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE; CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; TRANSIENT ISCHEMIC ATTACK; DUAL ANTIPLATELET THERAPY; RIVAROXABAN VS. WARFARIN; TOTAL KNEE ARTHROPLASTY; ASSAYS LABORATORY RECOMMENDATIONS;

D O I：

10.1093/europace/euab065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1612 / 1676

页数：65

共 50 条

[31] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
Chen, Kuan-Hsuan
Hsu, Yeh-Yun
Chou, Chian-Ying
Hsu, Chia-Chen
Chang, Shih-Lin
Yu, Wen-Chung
Chang, Yuh-Lih
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (07) : 1268 - 1280
[32] Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey
Vranckx, Pascal
Potpara, Tatjana
Dagres, Nikolaos
Heidbuchel, Hein
EUROPACE, 2016, 18 (07): : 1113 - 1116
[33] Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence
Calabro, Paolo
Gragnano, Felice
Cesaro, Arturo
Marsico, Fabio
Pariggiano, Ivana
Patti, Giuseppe
Moscarella, Elisabetta
Cavallari, Ilaria
Sardu, Celestino
Parato, Vito Maurizio
Renda, Giulia
Niccoli, Giampaolo
Marcucci, Rossella
De Caterina, Raffaele
ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (10) : 642 - 651
[34] Clinical Significance of Non-Vitamin K Antagonist Oral Anticoagulants in the Management of Atrial Fibrillation
Santarpia, Giuseppe
Curcio, Antonio
Sibilio, Gerolamo
Indolfi, Ciro
CIRCULATION JOURNAL, 2015, 79 (05) : 914 - 923
[35] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
Malagu, Michele
Longo, Filomena
Marchini, Federico
Sirugo, Paolo
Capanni, Andrea
Clo, Stefano
Mari, Elisa
Culcasi, Martina
Bertini, Matteo
BIOLOGY-BASEL, 2023, 12 (04):
[36] How safe are non-vitamin K antagonist oral anticoagulants in atrial fibrillation?
De Caterina, Raffaele
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0I) : 1 - 6
[37] Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Lee, S. I.
Sayers, M.
Lip, G. Y. H.
Lane, D. A.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (11) : 1341 - 1348
[38] Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
Caldeira, Daniel
David, Claudio
Costa, Joao
Ferreira, Joaquim J.
Pinto, Fausto J.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) : 111 - 118
[39] Treatment safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation
Hohnloser, S. H.
HERZ, 2016, 41 (01) : 37 - 45
[40] Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
Gabitova, Mariia A.
Krupenin, Pavel M.
Sokolova, Anastasiya A.
Napalkov, Dmitry A.
Fomin, Victor V.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 802 - 805

← 1 2 3 4 5 →